Literature DB >> 6242401

Huntington disease: estimation of heterozygote status using linked genetic markers.

P M Conneally, M R Wallace, J F Gusella, N S Wexler.   

Abstract

The recent finding of a closely linked DNA marker to the Huntington Disease gene allows the opportunity for prenatal and preclinical diagnosis. The methodology for using these markers for prediction in late age of onset disorders is discussed. Since these methods are both difficult and complex for the majority of genetic counselors, a simple solution is suggested. This involves using the well known linkage program LIPED and running it twice for a given consultand, once assuming he carries the gene and once that he is homozygous normal. This will allow accurate predictions for counselors with limited backgrounds in pedigree analysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6242401     DOI: 10.1002/gepi.1370010110

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  9 in total

Review 1.  Molecular biology in medicine.

Authors:  B D Young
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Determining informativity of marker typing for genetic counseling in a pedigree.

Authors:  L Sandkuyl; J Ott
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

3.  The population genetics of Duchenne: natural and artificial selection in Duchenne muscular dystrophy.

Authors:  J H Edwards
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

4.  Considerations in using linkage analysis as a presymptomatic test for Huntington's disease.

Authors:  L A Farrer; R H Myers; L A Cupples; P M Conneally
Journal:  J Med Genet       Date:  1988-09       Impact factor: 6.318

5.  A polymorphic DNA marker that represents a conserved expressed sequence in the region of the Huntington disease gene.

Authors:  M R Hayden; J Hewitt; J J Wasmuth; J J Kastelein; S Langlois; M Conneally; J Haines; B Smith; C Hilbert; D Allard
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

6.  Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.

Authors:  J M Vance; M A Pericak-Vance; L H Yamaoka; M C Speer; G O Rosenwasser; K Small; P C Gaskell; W Y Hung; M J Alberts; C S Haynes
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

7.  Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.

Authors:  Dwaine F Emerich; David J Mooney; Hannah Storrie; Rangasamy Suresh Babu; Jeffrey H Kordower
Journal:  Neurotox Res       Date:  2009-07-09       Impact factor: 3.911

8.  Evidence from family studies that the gene causing Huntington disease is telomeric to D4S95 and D4S90.

Authors:  C Robbins; J Theilmann; S Youngman; J Haines; M J Altherr; P S Harper; C Payne; A Junker; J Wasmuth; M R Hayden
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

9.  Improved predictive testing for Huntington disease by using three linked DNA markers.

Authors:  M R Hayden; C Robbins; D Allard; J Haines; S Fox; J Wasmuth; M Fahy; M Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.